<VariationArchive VariationID="2579228" VariationName="GRCh38/hg38 17p13.1(chr17:7454200-7454618)x0" VariationType="copy number loss" Accession="VCV002579228" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2744266" VariationID="2579228">
      <GeneList>
        <Gene Symbol="CHRNB1" FullName="cholinergic receptor nicotinic beta 1 subunit" GeneID="1140" HGNC_ID="HGNC:1961" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7445061" stop="7457710" display_start="7445061" display_stop="7457710" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NW_016107299.1" start="65518" stop="78167" display_start="65518" display_stop="78167" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7348405" stop="7360931" display_start="7348405" display_stop="7360931" Strand="+" />
          </Location>
          <OMIM>100710</OMIM>
        </Gene>
      </GeneList>
      <Name>GRCh38/hg38 17p13.1(chr17:7454200-7454618)x0</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7454200" stop="7454618" display_start="7454200" display_stop="7454618" variantLength="419" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh38/hg38 17p13.1(chr17:7454200-7454618)x0 AND Congenital myasthenic syndrome 2C" Accession="RCV003327667" Version="3">
        <ClassifiedConditionList TraitSetID="21217">
          <ClassifiedCondition DB="MedGen" ID="C4225373">Congenital myasthenic syndrome 2C</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31690835</ID>
          <ID Source="pmc">7313390</ID>
          <ID Source="DOI">10.1038/s41436-019-0686-8</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33060286</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33296147</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21217" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33151" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital myasthenic syndrome 2C</ElementValue>
                <XRef ID="MONDO:0014582" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myasthenic syndrome, congenital, 2c, associated with acetylcholine receptor deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMS2C</ElementValue>
                <XRef Type="MIM" ID="616314" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16083" />
                <XRef ID="16083" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301347</ID>
                <ID Source="BookShelf">NBK1168</ID>
              </Citation>
              <XRef ID="590" DB="Orphanet" />
              <XRef ID="C4225373" DB="MedGen" />
              <XRef ID="MONDO:0014582" DB="MONDO" />
              <XRef Type="MIM" ID="616314" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7549737" SubmissionDate="2023-09-11" DateLastUpdated="2023-09-16" DateCreated="2023-09-16">
        <ClinVarSubmissionID localKey="FAM16_11005|OMIM:616314|copy:0|refcopy:2" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004034200" DateUpdated="2023-09-16" DateCreated="2023-09-16" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
          <Comment>A homozygous deletion of exon 8 in CHRNB1 (NM_000747.3) was identified by exome sequencing in one individual with myasthenic syndrome ([GRCh 38] chr17:7454200_7454618 x0) (PMID: 33060286). The presence of this deletion was validated by a multiplex PCR assay (MLPA). These breakpoints have been estimated by exome sequencing only and therefore may not reflect the true breakpoints. Each copy of the variant was inherited from an unaffected heterozygous parent. The patient phenotype is nonspecific, but is consistent with cases described in the literature and/or published databases with overlapping variants. This exon deletion has also been reported in the literature in at least 4 individuals with myasthenic syndrome (PMID: 33296147). Of the 4 affected individuals, at least 2 were compound heterozygotes that carried a reported likely pathogenic variant in trans, which increases the likelihood that the exon 8 deletion variant is pathogenic (Variation ID: 504421; PMID: 33296147). This intragenic variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at exon 8 and leads to a premature termination codon. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of CHRNB1 is an established disease mechanism in autosomal recessive myasthenic syndrome (https://search.thegencc.org/genes). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive myasthenic syndrome. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 0.9 points, 3: 0 points, 4-5: 0.45 points; Total: 1.35 points; Riggs 2020 (PMID: 31690835).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">33060286</ID>
            </Citation>
            <Citation>
              <ID Source="PubMed">33296147</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHRNB1" />
          </GeneList>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="17" start="7454200" stop="7454618" variantLength="419" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">0</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="ReferenceCopyNumber">2</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616314" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13816677</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7549737" TraitType="Disease" MappingType="XRef" MappingValue="616314" MappingRef="OMIM">
        <MedGen CUI="C4225373" Name="Congenital myasthenic syndrome 2C" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

